Search

Layla D. Berry

Examiner (ID: 310, Phone: (571)272-9572 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1609, 1693, 1673
Total Applications
1764
Issued Applications
1125
Pending Applications
103
Abandoned Applications
569

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19003602 [patent_doc_number] => 20240067673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => MODIFIED NUCLEOSIDE OR NUCLEOTIDE [patent_app_type] => utility [patent_app_number] => 18/033037 [patent_app_country] => US [patent_app_date] => 2021-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 1377 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033037 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/033037
MODIFIED NUCLEOSIDE OR NUCLEOTIDE Oct 20, 2021 Pending
Array ( [id] => 17385677 [patent_doc_number] => 20220033529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => REGENERATED CELLULOSIC FIBRES SPUN FROM AN AQUEOUS ALKALINE SPINDOPE [patent_app_type] => utility [patent_app_number] => 17/503758 [patent_app_country] => US [patent_app_date] => 2021-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503758 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/503758
REGENERATED CELLULOSIC FIBRES SPUN FROM AN AQUEOUS ALKALINE SPINDOPE Oct 17, 2021 Abandoned
Array ( [id] => 20239594 [patent_doc_number] => 12419898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-23 [patent_title] => Synergistic composition for maintenance of healthy balance of microflora [patent_app_type] => utility [patent_app_number] => 17/496814 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3372 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496814 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/496814
Synergistic composition for maintenance of healthy balance of microflora Oct 7, 2021 Issued
Array ( [id] => 17385576 [patent_doc_number] => 20220033428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => LARGE SCALE PREPARATION OF PSEUDO-TRISACCHARIDE AMINOGLYCOSIDES AND OF INTERMEDIATES THEREOF [patent_app_type] => utility [patent_app_number] => 17/493672 [patent_app_country] => US [patent_app_date] => 2021-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24249 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493672 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/493672
LARGE SCALE PREPARATION OF PSEUDO-TRISACCHARIDE AMINOGLYCOSIDES AND OF INTERMEDIATES THEREOF Oct 3, 2021 Abandoned
Array ( [id] => 20621616 [patent_doc_number] => 12589110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-31 [patent_title] => Carbonated aerosol external preparation for skin [patent_app_type] => utility [patent_app_number] => 18/247598 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2035 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247598 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/247598
Carbonated aerosol external preparation for skin Sep 30, 2021 Issued
Array ( [id] => 18784836 [patent_doc_number] => 20230372492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 18/247049 [patent_app_country] => US [patent_app_date] => 2021-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247049 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/247049
DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME Sep 28, 2021 Pending
Array ( [id] => 19150126 [patent_doc_number] => 11975016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-07 [patent_title] => 2'-substituted-N [patent_app_type] => utility [patent_app_number] => 17/482224 [patent_app_country] => US [patent_app_date] => 2021-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34801 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482224 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/482224
2'-substituted-N Sep 21, 2021 Issued
Array ( [id] => 18724145 [patent_doc_number] => 20230338265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => NOVEL USE OF SACCHARIDE ISOMERATE [patent_app_type] => utility [patent_app_number] => 18/025380 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7602 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025380 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025380
NOVEL USE OF SACCHARIDE ISOMERATE Sep 9, 2021 Pending
Array ( [id] => 17704957 [patent_doc_number] => 20220204963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF [patent_app_type] => utility [patent_app_number] => 17/472367 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9478 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472367 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/472367
OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF Sep 9, 2021 Abandoned
Array ( [id] => 20911803 [patent_doc_number] => 12708638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-08-18 [patent_title] => Semicarbazone-based saponin conjugate [patent_app_type] => utility [patent_app_number] => 18/044950 [patent_app_country] => US [patent_app_date] => 2021-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 41 [patent_no_of_words] => 44987 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 265 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044950 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/044950
SEMICARBAZONE-BASED SAPONIN CONJUGATE Sep 8, 2021 Pending
Array ( [id] => 18675287 [patent_doc_number] => 20230312887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => PROCESS FOR PREPARING SUGAMMADEX [patent_app_type] => utility [patent_app_number] => 18/022570 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10727 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022570 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022570
PROCESS FOR PREPARING SUGAMMADEX Sep 7, 2021 Pending
Array ( [id] => 17312824 [patent_doc_number] => 20210401872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => HyperOsmolar Composition of Hyaluronic Acid [patent_app_type] => utility [patent_app_number] => 17/467918 [patent_app_country] => US [patent_app_date] => 2021-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467918 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/467918
Hyperosmolar composition of hyaluronic acid Sep 6, 2021 Issued
Array ( [id] => 17563152 [patent_doc_number] => 20220127301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => ASYMMETRIC AUXILIARY GROUP [patent_app_type] => utility [patent_app_number] => 17/465238 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465238 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465238
Asymmetric auxiliary group Sep 1, 2021 Issued
Array ( [id] => 19032467 [patent_doc_number] => 20240082282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => Hygromycin A Compositions and Methods of Use [patent_app_type] => utility [patent_app_number] => 18/042741 [patent_app_country] => US [patent_app_date] => 2021-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22523 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042741 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042741
Hygromycin A Compositions and Methods of Use Aug 31, 2021 Abandoned
Array ( [id] => 18716556 [patent_doc_number] => 11793879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Monolithic composition for dual-rate release with high drug loading [patent_app_type] => utility [patent_app_number] => 17/405610 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5682 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405610 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/405610
Monolithic composition for dual-rate release with high drug loading Aug 17, 2021 Issued
Array ( [id] => 17460611 [patent_doc_number] => 20220073916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => NOVEL PHOSPHORAMIDITES [patent_app_type] => utility [patent_app_number] => 17/405708 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23089 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405708 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/405708
NOVEL PHOSPHORAMIDITES Aug 17, 2021 Pending
Array ( [id] => 17314453 [patent_doc_number] => 20210403501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1 [patent_app_type] => utility [patent_app_number] => 17/445113 [patent_app_country] => US [patent_app_date] => 2021-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445113 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445113
Compositions and methods of modulating the immune response by activating alpha protein kinase 1 Aug 15, 2021 Issued
Array ( [id] => 18825281 [patent_doc_number] => 11840551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-12 [patent_title] => Compositions and methods of modulating the immune response by activating alpha protein kinase 1 [patent_app_type] => utility [patent_app_number] => 17/445122 [patent_app_country] => US [patent_app_date] => 2021-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 57 [patent_no_of_words] => 42545 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445122 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445122
Compositions and methods of modulating the immune response by activating alpha protein kinase 1 Aug 15, 2021 Issued
Array ( [id] => 17383845 [patent_doc_number] => 20220031697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumors [patent_app_type] => utility [patent_app_number] => 17/401600 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401600 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/401600
Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumors Aug 12, 2021 Abandoned
Array ( [id] => 18753952 [patent_doc_number] => 20230357303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B [patent_app_type] => utility [patent_app_number] => 18/020119 [patent_app_country] => US [patent_app_date] => 2021-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020119 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/020119
Hybrid amide derivatives of amphotericin B Aug 8, 2021 Issued
Menu